NCT02328209 Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration Status UNKNOWN Phase NA
NCT02328118 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China Status UNKNOWN Phase PHASE2/PHASE3
NCT02302079 A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE2
NCT02296567 Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT02291887 Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept Status COMPLETED Phase N/A
NCT02274259 Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen Status COMPLETED Phase PHASE4
NCT02258009 Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Status WITHDRAWN Phase PHASE4
NCT02222207 Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration Status TERMINATED Phase PHASE2
NCT02218177 Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD Status COMPLETED Phase N/A
NCT02186119 A Study of Abicipar Pegol in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT02181517 A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration Status COMPLETED Phase PHASE2
NCT02181504 A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration Status COMPLETED Phase PHASE2
NCT02174211 A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. Status COMPLETED Phase NA
NCT02169648 Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion Status UNKNOWN Phase NA
NCT02161575 Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD Status COMPLETED Phase PHASE4
NCT02144662 Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion Status COMPLETED Phase NA
NCT02134457 Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity Status COMPLETED Phase PHASE2
NCT02131350 Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema Status COMPLETED Phase PHASE4
NCT02127684 Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing Status WITHDRAWN Phase PHASE2